Hims & Hers Health Inc [HIMS] stock is trading at $59.78, up 7.75%. An important factor to consider is whether the stock is rising or falling in short-term value. The HIMS shares have gain 5.14% over the last week, with a monthly amount glided 2.05%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on June 04, 2025, when Needham reiterated its Buy rating and also boosted its price target to $65 from $61. Previously, TD Cowen downgraded its rating to Hold on April 29, 2025, and kept the price target unchanged to $30. On February 18, 2025, downgrade downgraded it’s rating to Equal-Weight and revised its price target to $60 on the stock. Citigroup downgraded its rating to a Sell and increased its price target to $25 on January 10, 2025. BTIG Research initiated its recommendation with a Buy and recommended $35 as its price target on January 07, 2025. Morgan Stanley started tracking with a Overweight rating for this stock on December 17, 2024, and assigned it a price target of $42. In a note dated November 14, 2024, BofA Securities downgraded an Underperform rating on this stock.
Hims & Hers Health Inc [HIMS] stock has fluctuated between $13.47 and $72.98 over the past year. Currently, Wall Street analysts expect the stock to reach $66.5 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $59.78 at the most recent close of the market. An investor can expect a potential return of 11.24% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
Hims & Hers Health Inc [NYSE:HIMS] reported sales of 1.78B for the trailing twelve months, which represents a growth of 110.67%. Gross Profit Margin for this corporation currently stands at 0.77% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.18, Equity is 0.36 and Total Capital is 0.18. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 56.48 points at the first support level, and at 53.17 for the second support level. However, for the 1st resistance point, the stock is sitting at 62.38, and for the 2nd resistance point, it is at 64.97.
Ratios To Look Out For
For context, Hims & Hers Health Inc’s Current Ratio is 1.59. On the other hand, the Quick Ratio is 1.32, and the Cash Ratio is 0.98. Considering the valuation of this stock, the price to sales ratio is 7.50, the price to book ratio is 24.33 and price to earnings (TTM) ratio is 87.02.
Transactions by insiders
Recent insider trading involved Melissa Baird, Officer, that happened on Jun 16 ’25 when 33333.0 shares were purchased. Officer, Dudum Andrew completed a deal on Jun 16 ’25 to buy 47534.0 shares. Meanwhile, Officer Boughton Soleil bought 5451.0 shares on Jun 16 ’25.
